The branched stent grafts market size is anticipated to expand at a substantial CAGR during the forecast period, between 2021 and 2028. The global branched stent grafts market's products are used in a variety of EVAR [endovascular aneurysm repair] operations. EVAR for significant aortic diseases such as aneurysms, traumatic ruptures, and dissections has acquired universal surgeon and patient acceptance owing to lower rates of morbidity and mortality.
Also, slow growth and poor net sales were seen by companies in the vascular stents market. Elective procedures were a low priority when hospitals shifted resources to ICUs, and the majority of them were postponed, affecting product demand. Furthermore, a quick change in the practice of vascular surgery had a significant impact on intensive and anesthetic care.
Since its inception in the early 1990s, EVAR has been proven to be a viable therapy option for abdominal aortic aneurysm [AAA]. The global population of people aged 60 and up, who are more likely to develop AAA, is growing, making it a high-impact key driver for market expansion over the forecast period.
The report on the global branched stent grafts market includes an assessment of the market, size, share, trends, segments, and regional markets. The study includes an overview as well as dynamics.
Attributes |
Details |
Report Title |
Branched Stent Grafts Market – Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2020 |
Historic Data |
2018-2019 |
Forecast Period |
2021-2028 |
Segmentation |
Types (Iliac Stent and Others), Applications (FEVAR, Chimney, and Others) |
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players covered in the Report |
Abbott, Alvimedica, Biotronik, Boston Scientific Corp, Cardinal Health (Cordis), Cook Medical, Endocr GmbH, Eucatech AG, Medtronic, Merit Medical Systems. |
Based on types, the global branched stent grafts market is bifurcated into iliac stent and others. The iliac stents segment accounted for a considerable market share in 2021 and is expected to grow at a significant CAGR during the forecast period. Increasing incidence of cardiovascular diseases [CVDs] over the world are expected to drive the market.
Rapid technical improvements and widespread acceptance of stenting operations are expected to enhance the segment's growth during the forecasted period. The other segment is expected to hold a substantial market share during forecast period. The others segment includes gastric, renal, femoral, celiac, fenestrated/branched, and super mesenteric stent graft systems. Growth of the market is attributed to increasing geriatric population with rising incidence of digestive problems.
Based on applications, the global branched stent grafts market is segmented into EVAR. The EVAR segment is further sub-segmented into fenestrated endovascular aortic aneurysm repair [FEVAR], chimney, and others. The others segment held a significant market share in 2021. Recent advancements in branched stent grafts have made it easier to treat a variety of aortic aneurysms, including those involving the visceral arteries.
Furthermore, new generation iliac bifurcated devices have good intraoperative and long-term results, which helps the market expand. The chimney segment is expected to grow at a substantial CAGR during the projected period. Endovascular aortic repair operations are becoming increasingly popular among patients around the world. In the United States, endovascular stent grafts are the preferred therapy for around 80% of aortic aneurysm cases. This is projected to fuel the market.
In terms of regions, the global branched stent grafts market is classified as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held a significant revenue share in 2021. The presence of well-developed healthcare infrastructure, significant actors, and reimbursement coverage in the region propel the market.
Furthermore, due to the huge presence of key participants, the regional market is quite competitive. On the other hand, Asia Pacific is anticipated to dominate the market during forecast period. The growth of market is attributed to growing healthcare spending and rapidly expanding medical tourism industry. The presence of high-quality healthcare infrastructure, convenience, and cheap treatment alternatives is likely to drive the regional market.
By Types
By Applications
By Regions
By Key Players
Key players in the global branched stent-grafts market include Abbott, Alvimedica, Biotronik, Boston Scientific Corp, Cardinal Health (Cordis), Cook Medical, Endocr GmbH, Eucatech AG, Medtronic, Merit Medical Systems. Some of these players are using several market strategies such as acquisitions, merger, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares and to generate revenue and raise their production line of the business in the coming years.
Some other reports from this category!